Literature DB >> 11293452

Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region.

T Seki1, T Tamai, K Ikeda, M Imamura, A Nishimura, N Yamashiki, T Nakagawa, K Inoue.   

Abstract

We report one patient who showed rapid progression of hepatocellular carcinoma (HCC) after undergoing transcatheter arterial chemoembolization (TACE) and percutaneous radiofrequency ablation (PRFA) for a small HCC measuring 2.5 cm in diameter. Enhanced magnetic resonance imaging (MRI) following treatment showed complete tumour necrosis and did not reveal the presence of a tumour around the treated area. Furthermore, the serum alpha-fetoprotein (AFP) level decreased at the completion of therapy. However, the HCC advanced in a very short time. Numerous tumours around the treated area were observed on enhanced computed tomography (CT) 50 days after PRFA. It is strongly suspected that the tumour was disseminated through the portal system because of the presence pattern of tumours. We believe this to be the first case illustrating a hepatic cancer that progressed rapidly following TACE and PRFA.

Entities:  

Mesh:

Year:  2001        PMID: 11293452     DOI: 10.1097/00042737-200103000-00014

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  32 in total

1.  Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver.

Authors:  Chiaki Kawamoto; Atsushi Yamauchi; Yoko Baba; Keiko Kaneko; Koji Yakabi
Journal:  J Gastroenterol       Date:  2009-11-20       Impact factor: 7.527

2.  Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Authors:  Keiichi Ito; Shigeyoshi Soga; Kenji Seguchi; Yusuke Shinchi; Ayako Masunaga; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Hiroshi Shinmoto; Tatsumi Kaji; Tomohiko Asano
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

3.  Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma.

Authors:  Martin-Walter Welker; Stephan Zangos; Susanne Kriener; Christian Mönch; Stefan Zeuzem; Joerg Trojan
Journal:  J Gastrointest Cancer       Date:  2010-06

4.  Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.

Authors:  Martin-Walter Welker; Joerg Trojan
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

5.  Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma.

Authors:  Koichi Obara; Nobuyuki Matsumoto; Masaru Okamoto; Minoru Kobayashi; Hiroki Ikeda; Hideaki Takahashi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; Chiaki Okuse; Michihiro Suzuki; Fumio Itoh
Journal:  Hepatol Int       Date:  2008-01-29       Impact factor: 6.047

6.  Radiofrequency (RF)-assisted hepatectomy may induce severe postoperative liver damage.

Authors:  Miyazawa Mitsuo; Torii Takahiro; Toshimitsu Yasuko; Aikawa Masayasu; Okada Katsuya; Shinozuka Nozomi; Otani Yoshihide; Koyama Isamu
Journal:  World J Surg       Date:  2007-09-18       Impact factor: 3.352

7.  Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: results and outcomes in 56 patients.

Authors:  Marc Giovannini; Vincent Moutardier; Carcline Danisi; Erwan Bories; Christian Pesenti; Jean-Robert Delpéro
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

8.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

9.  Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Authors:  Kosaku Moribata; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Tatsuya Shiraki; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Masao Ichinose
Journal:  World J Hepatol       Date:  2012-12-27

10.  Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.